Royal Bank of Canada reissued their outperform rating on shares of Oxford Biomedica (LON:OXB – Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. Royal Bank of Canada currently has a GBX 740 ($9.41) price objective on the biopharmaceutical company’s stock. Separately, Numis Securities reissued a hold rating and set a […]